Although MYBL2 is implicated in CRPC-Ad growth (55, 56), no studies have examined the specific functional and clinical implications of increased MYBL2 expression in driving phenotypic plasticity in prostate cancer. This evidence concerns the gene MYBL2 and prostate cancer.